BioSpace News Archive

Biotech Bay

Sanofi and Roche Take Trump’s No-Drug-Price-Increase Pledge, at Least for Now

It was reported today that U.S.-based Merck & Co. will lower the price of some of its drug. It appears to be rippling through the industry, largely in an attempt to stay out of the way of Trump’s attack-tweets.

July 20, 2018
·
2 min read
·
Mark Terry
FDA

Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a Year

Shares of Agios Pharmaceuticals jumped this morning after the company said the FDA approved its oral leukemia treatment Tibsovo (ivosidenib). It’s the second approval for the company in less than a year.

July 20, 2018
·
2 min read
·
Alex Keown
Business

Two Artificial Intelligence Companies Partner to Take on DMD and Orphan Diseases

For many companies, artificial intelligence has become a key tool in drug development. Now, two companies that specialize in AI-backed drug development are teaming up to take on the rare disease known as Duchene Muscular Dystrophy.

July 20, 2018
·
2 min read
·
Alex Keown